TITLE

Modeling the Potential Public Health Impact of Imperfect HIV Vaccines

AUTHOR(S)
Blower, Sally
PUB. DATE
October 2005
SOURCE
Journal of Infectious Diseases;10/15/2005, Vol. 192 Issue 8, p1494
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor about the public health impact of imperfect HIV vaccines.
ACCESSION #
18544010

 

Related Articles

  • Private sector needs incentives for AIDS vaccine. Irvine, Benedict // BMJ: British Medical Journal (International Edition);10/23/2004, Vol. 329 Issue 7472, p979 

    Presents a letter to the editor regarding an article by Tucker and Mazithulela which discussed the need the private sector has for an AIDS vaccine.

  • Coping with Viral Diversity in HIV Vaccine Design: A Response to Nickle et al. Fischer, Will; H. X. Liao; Haynes, Barton F.; Letvin, Norman L.; Korber, Bette // PLoS Computational Biology;Jan2008, Vol. 4 Issue 1, pe15 

    A letter to the editor is presented in response to the article "Coping with Viral Diversity in HIV Vaccine Design," by D. C. Nickle and colleagues in a previous issue.

  • Comparison of Immunogen Designs That Optimize Peptide Coverage: Reply to Fischer et al. Nickle, David C.; Rolland, Morgane; Mullins, James I.; Heckerman, David; Kirovski, Darko; Jojic, Vladimir; Pond, Sergei Kosakovsky // PLoS Computational Biology;Jan2008, Vol. 4 Issue 1, pe25 

    A response by D. C. Nickle and colleagues to a letter to the editor about their article "Coping with Viral Diversity in HIV Vaccine Design" in a previous issue is presented.

  • The societal costs of failing to develop a vaccine. Norris, Jeremiah // BMJ: British Medical Journal (International Edition);7/14/2007, Vol. 335 Issue 7610, p60 

    A letter to the editor is presented in response to the article "Quest for the AIDS vaccine," by A. Tonks in the June 30, 2007 issue.

  • Almost correct . Gore, Quentin // New Scientist;7/14/90, Vol. 127 Issue 1725, p68 

    Presents a letter to the editor in response to an article about a new AIDS vaccine, in the June 16 issue.

  • An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Evans, David J.; McKeating, Jane; Meredith, Janet M.; Burke, Karen L.; Katrak, Kersi; John, Ann; Ferguson, Morag; Minor, Philip D.; Weiss, Robin A.; Almond, Jeffrey W. // Nature;6/1/1989, Vol. 339 Issue 6223, p385 

    The Sabin type 1 vaccine strain of poliovirus is probably the safest and most successful live-attenuated vaccine virus used in humans. Its widespread use since the early 1960s has contributed significantly to the virtual eradication of poliomyelitis in developed countries. We have reported...

  • NIAID to test new AIDS vaccines on pregnant women with HIV. Doepel, Laurie K. // Public Health Reports;Jul/Aug93, Vol. 108 Issue 4, p526 

    Announces that the National Institute of Allergy and Infectious Diseases (NIAID) has begun the first clinical trials of therapeutic AIDS vaccine for pregnant women who are infected with HIV, but otherwise healthy. Hopes of stimulating antibody responses that will cross the placenta and protect...

  • HIV vaccine gets booster. Catalano, Peter // Insight on the News;02/17/97, Vol. 13 Issue 6, p42 

    Reports on the AIDS research community's new attitude toward developing and testing an AIDS vaccine. Allocation of funds for vaccine research; Retaining of HIV distinct pattern in the human lymphocytes; Prevention of HIV from attaching itself to immune cells through booster shots. INSET: AIDS...

  • Phase III Study Set to Evaluate Efficacy of Antiretroviral AIDS Vaccine. Guttman, Cheryl // Dermatology Times;Jun99, Vol. 20 Issue 6, p39 

    Reports on the launch of Phase III clinical trials in the United States to evaluate the efficacy of antiretroviral AIDS vaccines. Contributing factors to elusiveness of finding a cure; Goals; Fomivirsen sodium for cytomegalovirus retinitis; Famciclovir for treatment of zoster; Safety and...

  • Experts agree an AIDS vaccine is doable. Gallagher, John // Advocate;02/18/97, Issue 727, p35 

    Reports that experts in the United States agreed that the creation of a vaccination for AIDS was possible. Reasons experts were optimistic; Indepth look at the advances made with the treatment of AIDS; Comments from Julie McElrath, an associate professor of medicine at the University of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics